インドのファンドマネージャーは4月、製薬会社やノンバンク（非銀行金融会社）に新規投資を行った。これは、原油価格や西アジアの緊張をめぐる懸念の中で、ディフェンシブ銘柄をターゲットにした動きである。
セマグルチドの特許満期といった機会があることから、製薬企業が特に注目を集めた。株式運用ファンドの買い付け対象には、Aurobindo Pharma、Sun Pharma、Torrent Pharma、Mankind Pharmaといった銘柄が含まれている。
AIによるレポート AIによって生成された画像
Among 68 high-priced stocks trading above Rs 5,000 on the BSE, FY26 has brought more declines than gains amid global uncertainty and geopolitical tensions. The top six laggards fell 25-40%, while top gainers surged 40-130%. Institutional holdings vary across these stocks.
India's small-cap stocks surged 17.1% in April, marking their best monthly performance in at least a decade. The Nifty Smallcap 250 index rebounded sharply after a steep sell-off in March. Local investors snapped up undervalued stocks with strong growth potential.
AIによるレポート
Retail investors put ₹38,440 crore into equity mutual funds last month, a modest decline from March levels. The dip occurred amid uncertainty over oil prices and lower SIP collections.
Several brokerages have identified 10 largecap stocks in India with significant upside potential despite rising oil prices from the US-Iran war. Crude oil has surpassed $125 per barrel, fueling inflation fears and market uncertainty. Stocks like HDFC Bank and Bharti Airtel top the lists from firms including Jefferies and Axis Direct.
AIによるレポート
Nine BSE smallcap companies delivered standout performances in the March 2026 quarter, with net profits surging over 50% year-on-year and share prices rising 50% to 170% in the past year. Four of these stocks became multibaggers, more than doubling investor returns. Data from ACE Equity highlights the momentum amid mixed results from 168 reporting firms.
Equity mutual fund inflows in India surged 56% to Rs 40,450 crore in March from Rs 25,977 crore in February, according to AMFI data. Flexi-cap funds led with a record Rs 10,054 crore, while nine categories overall saw positive inflows. Small-cap and mid-cap funds also posted strong gains amid market corrections.
AIによるレポート
Indian IT stocks experienced a brief rebound on Wednesday, halting a five-day losing streak. Analysts, however, caution that this uptick may not last, with persistent bearish sentiments in derivatives. The sector has been under pressure in February amid growing concerns over AI's impact on revenues.